Specialty drug costs nearly tripled over six years, while opioid utilization dropped and prescribing patterns shifted based on claim stage, according to Enlyte.
Workers’ compensation prescription costs and utilization saw notable changes in 2023, with an overall decrease in per claim costs and continued declines in opioid prescribing, according to an analysis by Enlyte.
Despite these promising trends, certain therapeutic classes experienced double-digit cost increases as the industry grappled with addressing new prescribing patterns. In 2023, utilization per claim decreased by 5.2% and cost per claim edged down 0.2%.
These are some of the findings of Part 1 of a four-part series titled, “2024 Pharmacy Solutions Drug Trends Report” by Enlyte. This first installment focuses on retail and mail-order transactions billed through Enlyte’s combined pharmacy benefit management programs.
However, cost per script rose 5.2% across the classes, per the report. In fact, eight of the top 10 therapeutic classes experienced an increase in cost per script, with two classes jumping by…
